• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幼年特发性关节炎的管理

Management of juvenile idiopathic arthritis.

作者信息

Sawhney Sujata

机构信息

Sir Ganga Ram Hospital, New Delhi, India.

出版信息

Indian J Pediatr. 2002 Oct;69(10):893-7. doi: 10.1007/BF02723715.

DOI:10.1007/BF02723715
PMID:12450301
Abstract

Juvenile idiopathic arthritis (JIA) is a relatively uncommon disorder in childhood. Expertise however should be the corner stone of care of children with JIA, as early appropriate treatment is mandatory to ensure best possible short and long-term outcome for children with JIA. Therefore comprehensive treatment centers (with multi disciplinary teams) should be based in tertiary level academic centers. This article deals with both specific and generic issues encountered in managing children with JIA.

摘要

幼年特发性关节炎(JIA)是儿童期相对罕见的一种疾病。然而,专业知识应是JIA患儿护理的基石,因为早期进行恰当治疗对于确保JIA患儿获得最佳的短期和长期预后至关重要。因此,综合性治疗中心(配备多学科团队)应设立在三级学术中心。本文探讨了JIA患儿管理中遇到的具体问题和一般问题。

相似文献

1
Management of juvenile idiopathic arthritis.幼年特发性关节炎的管理
Indian J Pediatr. 2002 Oct;69(10):893-7. doi: 10.1007/BF02723715.
2
Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review.肿瘤坏死因子抑制剂在幼年特发性关节炎治疗中的应用:循证评价。
Paediatr Drugs. 2010 Dec 1;12(6):367-77. doi: 10.2165/11532610-000000000-00000.
3
Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.与依那西普治疗幼年特发性关节炎反应相关的因素。
JAMA. 2011 Dec 7;306(21):2340-7. doi: 10.1001/jama.2011.1671. Epub 2011 Nov 6.
4
Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis.在先前难治性幼年特发性关节炎患者中使用依那西普时,健康相关生活质量得到显著改善。
Ann Rheum Dis. 2010 Jan;69(1):138-42. doi: 10.1136/ard.2009.111260.
5
Safety and efficacy of etanercept in children with the JIA categories extended oligoarthritis, enthesitis-related arthritis and psoriasis arthritis.依那西普治疗幼年特发性关节炎扩展型少关节炎、附着点炎相关关节炎和银屑病关节炎患儿的安全性及有效性。
Clin Rheumatol. 2015 Jan;34(1):61-9. doi: 10.1007/s10067-014-2744-6. Epub 2014 Jul 18.
6
Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study.依那西普治疗幼年特发性关节炎附着点炎症型患者的疗效和安全性:一项 III 期随机、双盲研究的结果。
Arthritis Rheumatol. 2015 May;67(8):2240-9. doi: 10.1002/art.39145.
7
Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis.
Rheumatology (Oxford). 2002 Feb;41(2):228-9. doi: 10.1093/rheumatology/41.2.228.
8
Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.在一名类风湿因子阳性的多关节型幼年特发性关节炎患儿中,将治疗药物从依那西普转换为英夫利昔单抗。
Mod Rheumatol. 2007;17(6):526-8. doi: 10.1007/s10165-007-0634-3. Epub 2007 Dec 20.
9
Lipid profiles alter from pro-atherogenic into less atherogenic and proinflammatory in juvenile idiopathic arthritis patients responding to anti TNF-α treatment.在对抗TNF-α治疗有反应的幼年特发性关节炎患者中,血脂谱从促动脉粥样硬化转变为动脉粥样硬化性和促炎作用较弱的状态。
PLoS One. 2014 Mar 6;9(6):e90757. doi: 10.1371/journal.pone.0090757. eCollection 2014.
10
Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.日本甲氨蝶呤治疗抵抗性多关节病程幼年特发性关节炎患者长期使用依那西普的安全性和疗效。
Mod Rheumatol. 2012 Sep;22(5):720-6. doi: 10.1007/s10165-011-0578-5. Epub 2012 Jan 4.

本文引用的文献

1
Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.改善病情抗风湿药的安全性与有效性:聚焦于依那西普的获益与风险
Drug Saf. 2002;25(3):173-97. doi: 10.2165/00002018-200225030-00004.
2
Current treatment of juvenile rheumatoid arthritis.青少年类风湿性关节炎的当前治疗方法。
Pediatrics. 2002 Jan;109(1):109-15. doi: 10.1542/peds.109.1.109.
3
Diagnosis and management of juvenile idiopathic arthritis: current status.青少年特发性关节炎的诊断与管理:现状
Indian Pediatr. 2001 Oct;38(10):1083-9.
4
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders.巨噬细胞活化综合征:风湿性疾病的一种潜在致命并发症。
Arch Dis Child. 2001 Nov;85(5):421-6. doi: 10.1136/adc.85.5.421.
5
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.与英夫利昔单抗(一种肿瘤坏死因子α中和剂)相关的结核病。
N Engl J Med. 2001 Oct 11;345(15):1098-104. doi: 10.1056/NEJMoa011110.
6
Prognostic factors in juvenile idiopathic arthritis.青少年特发性关节炎的预后因素
Curr Rheumatol Rep. 2001 Oct;3(5):371-8. doi: 10.1007/s11926-996-0006-6.
7
A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study.依那西普与甲氨蝶呤联合治疗难治性幼年特发性关节炎的一项初步研究。
Ann Rheum Dis. 2001 Apr;60(4):410-2. doi: 10.1136/ard.60.4.410.
8
A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis.关节内注射己曲安奈德治疗幼年慢性关节炎疗效的亚组特异性评估
J Rheumatol. 2000 Nov;27(11):2696-702.
9
Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study.阿仑膦酸钠治疗儿童弥漫性结缔组织病骨质疏松症的疗效和安全性:一项前瞻性多中心研究。
Arthritis Rheum. 2000 Sep;43(9):1960-6. doi: 10.1002/1529-0131(200009)43:9<1960::AID-ANR6>3.0.CO;2-J.
10
Methotrexate: more questions than answers.甲氨蝶呤:问题多于答案。
J Rheumatol. 2000 Aug;27(8):1834-5.